Back to Journals » ClinicoEconomics and Outcomes Research

ClinicoEconomics and Outcomes Research

ISSN: 1178-6981


Journal Articles:

- 875 records -

Modelling the Costs of Sublingual Immunotherapy versus Subcutaneous Immunotherapy Based on Clinical Appointments and Impacts of Patient Travel in Sweden

Cardell LO, Sterner T, Ahmed W, Slættanes AK, Svärd M, Pollock RF

ClinicoEconomics and Outcomes Research 2024, 16:493-506

Published Date: 10 June 2024

Cost-Effectiveness Analysis of the Oncotype DX Breast Recurrence Score® Test from a US Societal Perspective

Berdunov V, Cuyun Carter G, Laws E, Luo R, Russell CA, Campbell S, Abdou Y, Force J

ClinicoEconomics and Outcomes Research 2024, 16:471-482

Published Date: 4 June 2024

Development of an Efficient and Effective Clinical Pathway for Cesarean Section in West Sumatra (Indonesia)

Aladin A, Taifur WD, Aljunid SM, Ocviyanti D

ClinicoEconomics and Outcomes Research 2024, 16:461-469

Published Date: 30 May 2024

Oral Prostacyclin Pathway Agents Used in PAH: A Targeted Literature Review

Burger CD, Tsang Y, Chivers M, Vekaria RV, Doad G, Atkins N, Panjabi S

ClinicoEconomics and Outcomes Research 2024, 16:447-459

Published Date: 30 May 2024

Clinical and Economic Value of a Biosimilar Portfolio to Stakeholders: An Integrative Literature Review

Fox GE, Bernauer M, Stephens JM, Jackson B, Roth JA, Shelbaya A

ClinicoEconomics and Outcomes Research 2024, 16:247-416

Published Date: 13 May 2024

Expanding Access to Patient Care in Community Pharmacies for Minor Illnesses in Washington State

Akers JM, Miller JC, Seignemartin B, MacLean LG, Mandal B, Kogan C

ClinicoEconomics and Outcomes Research 2024, 16:233-246

Published Date: 3 May 2024

Cost-Utility Analysis Comparing Pegcetacoplan to Anti-C5 Monoclonal Antibodies in the Treatment of Paroxysmal Nocturnal Hemoglobinuria

Di Matteo S, Freilone R, Bruno GM, Notaro R, Moumene S, Martone N, Teruzzi C, Ciccarone A, Colombo GL

ClinicoEconomics and Outcomes Research 2024, 16:225-232

Published Date: 11 April 2024

Cost-Savings Associated with Multi-Disciplinary Team Approach for Reducing Macrovascular and Microvascular Complications in Patients with Type 2 Diabetes: A Predictive Model

Alshowair A, Altamimi S, Alruhaimi FA, Alshahrani S, Alsuwailem F, Alkhaldi M, Abdalla H, Alkhuraiji FH, Alaqeel MS, Almureef SS, Alhawasy S, Abdel-Azeem A

ClinicoEconomics and Outcomes Research 2024, 16:211-223

Published Date: 4 April 2024

Evaluating Health Expenditure Trends and Disease Burden in India: A Cost per DALY Approach

Bagepally BS, Kumar S S, Sasidharan A

ClinicoEconomics and Outcomes Research 2024, 16:187-196

Published Date: 26 March 2024

Key Performance Indicators: A Framework for Allied Healthcare Educational Institutions

Sreedharan JK, Subbarayalu AV, Kamalasanan A, Albalawi I, Krishna GG, Alahmari AD, Alsalamah JA, Alkhathami MG, Alenezi M, Alqahtani AS, Alahmari M, Phillips MR, MacDonald J

ClinicoEconomics and Outcomes Research 2024, 16:173-185

Published Date: 26 March 2024

The Economic Burden of Diabetic Retinopathy in Jordan: Cost Analysis and Associated Factors

Al-Dwairi RA, Aleshawi A, Abu-zreig L, Al-Shorman W, Al Beiruti S, Alshami AO, Allouh MZ

ClinicoEconomics and Outcomes Research 2024, 16:161-171

Published Date: 15 March 2024

Medical Costs Associated with High/Moderate/Low Likelihood of Adult Growth Hormone Deficiency: A Healthcare Claims Database Analysis

Yuen KC, Blevins LS, Clemmons DR, Faurby M, Hoffman AR, Kelepouris N, Kerr JM, Tarp JM, Fleseriu M

ClinicoEconomics and Outcomes Research 2024, 16:133-147

Published Date: 8 March 2024

The Economic Impact of Obesity in Turkey: A Micro-Costing Analysis

Gogas Yavuz D, Akhtar O, Low K, Gras A, Gurser B, Yilmaz ES, Basse A

ClinicoEconomics and Outcomes Research 2024, 16:123-132

Published Date: 5 March 2024

The Economic Burden of the COVID-19 Pandemic in State of Kuwait

Nur AM, Aljunid SM, Almari M

ClinicoEconomics and Outcomes Research 2024, 16:111-122

Published Date: 4 March 2024

Comparative Costs to Medicare and Medicare Beneficiaries of Alternative AF Stroke Risk Reduction Strategies

Reddy VY, Zhong Y, McGovern AM, Amorosi SL, Gavaghan MB, Hertz DS, Low K, Freeman S, Holmes DR Jr

ClinicoEconomics and Outcomes Research 2024, 16:81-96

Published Date: 14 February 2024

Pharmacoeconomic Evaluation of Costs of Myelomeningocele and Meningocele Treatment and Screening

Hoxha M, Malaj V, Zappacosta B, Firza N

ClinicoEconomics and Outcomes Research 2024, 16:69-80

Published Date: 9 February 2024

Disutility of Cognitive Processing Speed (CPS) Impairment in the Context of Multiple Sclerosis: A Time Trade-Off (TTO) Elicitation Study

Benedict RH, Vo P, Adlard N, Grennan O, Enstone A, Bridge D, Wyn R, Cohan SL

ClinicoEconomics and Outcomes Research 2024, 16:55-67

Published Date: 8 February 2024

Methods used to account for caregivers’ sex and gender within studies examining the financial burden of caregivers of children and adolescents : Results from a scoping review

Guertin JR, Gilbert-Ouimet M, Dugas M, Carnovale V, Jalbert L, Svyntozelska O, Demers J, Matteau L, Bergeron F, LeBlanc A

ClinicoEconomics and Outcomes Research 2024, 16:35-53

Published Date: 26 January 2024

The Cost-Effectiveness of Dolutegravir in Combination with Tenofovir and Lamivudine for HIV Therapy: A Systematic Review

Aprilianti S, Utami AM, Suwantika AA, Zakiyah N, Azis VI

ClinicoEconomics and Outcomes Research 2024, 16:25-34

Published Date: 26 January 2024

Budget Impact Analysis of Minimally Invasive versus Open Transforaminal Lumbar Interbody Fusion for Lumbar Degenerative Disease: A European Hospital Perspective

Bassani R, Galvain T, Battaglia S, Maheswaran H, Wright G, Kambli A, Piemontese A

ClinicoEconomics and Outcomes Research 2024, 16:13-24

Published Date: 18 January 2024

Exploring the Cost-Utility of a Biomarker Predicting Persistent Severe Acute Kidney Injury: The Case of C-C Motif Chemokine Ligand 14 (CCL14)

Echeverri J, Martins R, Harenski K, Kampf JP, McPherson P, Textoris J, Koyner JL

ClinicoEconomics and Outcomes Research 2024, 16:1-12

Published Date: 12 January 2024

What to Expect in 2024: Important Health Economics and Outcomes Research (HEOR) Trends

Abraham I, Hiligsmann M, Lee KKC, Citrome L, Colombo GL, Gregg M

ClinicoEconomics and Outcomes Research 2023, 15:799-809

Published Date: 21 December 2023

The Cost-Effectiveness of Chin Tuck Against Resistance Compared to Usual Care in Citizens with Oropharyngeal Dysphagia – An Economic Evaluation

Dyreborg L, Raunbak SM, Sørensen SS, Melgaard D, Westmark S

ClinicoEconomics and Outcomes Research 2023, 15:787-797

Published Date: 20 December 2023

Estimating the Cost of Spinopelvic Complications After Adult Spinal Deformity Surgery [Letter]

Winarni S, Nugroho HSW, Retnaningtyas E

ClinicoEconomics and Outcomes Research 2023, 15:773-774

Published Date: 23 November 2023

Estimating the Cost of Spinopelvic Complications After Adult Spinal Deformity Surgery

Zuckerman SL, Cher D, Capobianco R, Sciubba D, Polly DW

ClinicoEconomics and Outcomes Research 2023, 15:765-772

Published Date: 9 November 2023

Cost-Effectiveness of Acthar Gel versus Standard of Care for the Treatment of Advanced Symptomatic Sarcoidosis

Bindra J, Chopra I, Hayes K, Niewoehner J, Panaccio M, Wan GJ

ClinicoEconomics and Outcomes Research 2023, 15:739-752

Published Date: 17 October 2023

Examining the Burden of Potentially Avoidable Heart Failure Hospitalizations

Zilberberg MD, Nathanson BH, Sulham K, Mohr JF, Goodwin M, Shorr AF

ClinicoEconomics and Outcomes Research 2023, 15:721-731

Published Date: 29 September 2023

Medical Costs in Patients with Hyperkalemia on Long-Term Sodium Zirconium Cyclosilicate Therapy: The RECOGNIZE II Study

Agiro A, Dwyer JP, Oluwatosin Y, Desai P

ClinicoEconomics and Outcomes Research 2023, 15:691-702

Published Date: 21 September 2023

Using a Modified Delphi Panel to Estimate Health Service Utilization for Patients with Advanced and Non-Advanced Systemic Light Chain Amyloidosis

Gertz M, Abonour R, Gibbs SN, Finkel M, Landau H, Lentzsch S, Lin G, Mahindra A, Quock T, Rosenbaum C, Rosenzweig M, Sidana S, Tuchman SA, Witteles R, Yermilov I, Broder MS

ClinicoEconomics and Outcomes Research 2023, 15:673-680

Published Date: 11 September 2023

Cost-Effectiveness of Lorlatinib for the Treatment of Adult Patients with Anaplastic Lymphoma Kinase Positive Advanced Non-Small Cell Lung Cancer in Spain

Presa M, Vicente D, Calles A, Salinas-Ortega L, Naik J, García LF, Soto J

ClinicoEconomics and Outcomes Research 2023, 15:659-671

Published Date: 7 September 2023

The Cost of Maternal Complications and Its Associated Factors Among Mothers Attending Public Hospitals in Harari Region and Dire Dawa City Administration, Eastern Ethiopia: An Institution-Based Cross-Sectional Study

Shawel S, Hawulte Ayele B, Dessie Y, Tura AK, Dinsa G, Tekola A, Mandefro M, Masrie A, Tamire A, Tefasa OK

ClinicoEconomics and Outcomes Research 2023, 15:645-658

Published Date: 7 September 2023

Treatment Patterns and Healthcare Resource Use in Medicare Beneficiaries with Parkinson’s Disease

Song Y, E JY, Guo T, Sasane R, Arcona S, Keshava N, Wu E

ClinicoEconomics and Outcomes Research 2023, 15:631-643

Published Date: 2 August 2023

Cost Analysis of Chronic Kidney Disease Patients in Indonesia

Sunariyanti E, Andayani TM, Endarti D, Puspandari DA

ClinicoEconomics and Outcomes Research 2023, 15:621-629

Published Date: 28 July 2023

Economic Burden Associated with the Treatment with a Cardiovascular Polypill in Secondary Prevention in Spain: Cost-Effectiveness Results of the NEPTUNO Study

Cordero A, Dalmau González-Gallarza R, Masana L, Fuster V, Castellano JM, Ruiz Olivar JE, Zsolt I, Sicras-Mainar A, González Juanatey JR

ClinicoEconomics and Outcomes Research 2023, 15:559-571

Published Date: 19 July 2023

More articles